The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis

Journal of Surgical Research

Volumn 81, Issue 1, 1999, Pages 101-107

  Erickson, Brian A ^a   Longo, Walter E ^a   Panesar, Ninder ^a   Mazuski, John E ^a   Kaminski, Donald L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; VALERYLSALICYLIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH INHIBITION; INTESTINE EPITHELIUM CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032854663     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5511     Document Type: Article

References (41)

1. Eberhart C. E., DuBois R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:1995;285.
2. Fu J. Y., Masferrer J. L., Seibert K., Raz A., Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265:1990;16737.
3. Capdevila J. H., Wei S., Yan J., Karara A., Jacobson H. R., Falck J. R., Guengerich F. P., DuBois R. N. Cytochrome P-450 arachidonic acid epoxygenase: Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267:1992;21720.
4. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc. Natl. Acad. Sci. USA. 86:1989;1657.
5. DuBois R. N., Smalley W. E. Cyclooxygenase, NSAIDs and colorectal cancer. J. Gastroenterol. 31:1996;898.
6. Shiff S. J., Rigas B. Non-steroidal anti-inflammatory drugs and colorectal cancer; evolving concepts of their chemopreventive actions. Gastroenterology. 113:1997;1992.
7. Ara G., Teicher B. A. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Pros. Leuk. Ess. Fatty Acids. 54:1996;3.
8. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukotrienes Essent. Fatty Acids. 54:1996;83.
9. Wu K. K. Cyclooxygenase 2 induction: Molecular mechanisms and pathophysiologic roles. J. Lab. Clin. Med. 128:1996;242.
10. Levy G. N. Prostaglandin H synthase, non-steroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234.
11. Davies G. R., Rampton D. S. Eicosanoids: Role in gastrointestinal inflammation and cancer. Eur. J. Gastroenterol. Hepat. 9:1997;1033.
12. Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B. Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237.
13. Longo W. E., Damore L. J., Mazuski J. E., Smith G. E., Panesar N., Kaminski D. L. The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation. Med. Inflamm. 7:1998;1.
14. Gordon J. I. Intestinal epithelial differentiation: New insights from chimeric and transgenic mice. J. Cell. Biol. 108:1989;1187.
15. DuBois R. N., Tsujii M., Bishop P., Awad J. A., Makita K., Lanahan A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol. 266:1994;G822.
16. Blay J., Brown K. Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine. Biochem. J. 225:1985;85.
17. Ravikumar T. S., D'Emilia J., Cocchiaro C., Wolf B., King V., Steele G. Experimental liver metastases. Implications of clonal proclivity and organ specificity. Arch. Surg. 124:1989;49.
18. Brand M. I., Casillas S., Dietz D. W., Milsom J., Vladisavljevic A. Development of a reliable colorectal cancer liver metastases model. J. Surg. Res. 63:1996;425.
19. Casillas S., Dietz D. W., Brand M. I., Jones S. C., Vladisavljevic B. S., Milsom J. W. Perfusion to colorectal cancer liver metastases is not uniform and depends on tumor location and feeding vessels. J. Surg. Res. 67:1997;179.
20. Bhattacharyya D. K., Lecomte M., Dunn J., Morgans D. J., Smith W. L. Selective inhibition of prostaglandin endoperoxide synthase-1 (cycylooxygenase-1) by valerylsalicyclic acid. Arch. Biochem. Biophys. 317:1995;119.
21. Siebert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013.
22. Nag M. K., Deshpande Y. G., Beck D., Li A., Kaminski D. L. The effect of lysolecithin on prostanoid and platelet-activating factor formation by human gallbladder mucosal cells. Med. Inflamm. 4:1995;90.
23. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248.
24. Hague A., Manning A. M., Hanlon K. A., Huschtscha L. I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer. 55:1993;495.
25. Heerdt B. G., Houston M. A., Augenlicht L. H. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54:1994;3288.
26. Elder D. J., Hague A., Hicks D. J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res. 56:1996;2273.
27. Hara A., Yoshimi N., Niwa M., Ino N., Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor in human colorectal cancer cell lines. Jpn. J. Cancer Res. 88:1997;600.
28. Kune G., Kune S., Watson L. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48:1988;4399.
29. Thun M. J. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev. 13:1994;269.
30. Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., DuBois R. N. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas. Gastroenterology. 107:1994;1183.
31. Tsuji S., Kawano S., Sawaoka H., Takei Y., Kobayashi I., Nagano K., Fusamoto H., Kamada T. Evidence for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukotrienes Essent. Fatty Acids. 55:1996;179.
32. Coffey R. J., Hawkey C. J., Damstrup L., Graves-Deal R., Daniel V. C., Dempsey P. J., Chinery R., Kirkland S. C., DuBois R. N., Jetton T. L., Morrow J. D. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci. USA. 94:1997;657.
33. Sheng G. G., Shao J., Sheng H., Hooton E. B., Isakson P. C., Morrow J. D., Coffey R. J., DuBois R. N., Beauchamp R. D. A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology. 113:1997;1883.
34. Sheng H., Shao J., Kirkland S. C., Isakson P., Coffey R. J., Morrow J., Beauchamp R. D., DuBois R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99:1997;2254.
35. Elder D. J. E., Halton D. E., Hague A., Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (Cox-2) selective non-steroidal anti-inflammatory drug: Independence from COX-2 protein expression. Clin. Cancer Res. 3:1997;1679.
36. 2. Cancer Res. 58:1998;362.
37. Kessler W. F., Shires G. T., Fahey T. J. Surgical complications of non-steroidal anti-inflammatory drug-induced small bowel ulceration. J. Am. Coll. Surg. 185:1997;250.
38. Meade E. A., Smith W. L., DeWitt D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:1993;6610.
39. Anderson K. M., Roshak A., Winkler J. D., McCord M., Marshall L. A. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem. 272:1997;30504.
40. Reich R., Martin G. R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins. 51:1996;1.
41. Tsuji M., Kawano S., DuBois R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA. 94:1997;3336.